Essex Woodlands Management, Inc. Long-Term Concentrated

Location: The Woodlands, TX

CIK: 0001542339 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (11)

— ABIOMED INC 39.6%

Value $60.04M Shares 3,150,000 Est. Cost $21.56 Unrealized —

— ENDOLOGIX INC 22.5%

Value $34.03M Shares 1,165,428 Est. Cost $13.28 Unrealized —

— ACURA PHARMACEUTICALS INC 12.4%

Value $18.84M Shares 10,294,886 Est. Cost $1.82 Unrealized —

— HORIZON PHARMA INC 11.9%

Value $18.01M Shares 5,815,940 Est. Cost $2.26 Unrealized —

— ZIOPHARM ONCOLOGY INC 6.4%

Value $9.721M Shares 2,764,908 Est. Cost $1.96 Unrealized —

— CHINA CORD BLOOD CORP 2.6%

Value $3.943M Shares 1,037,690 Est. Cost $2.81 Unrealized —

MNOV MEDICINOVA INC 2.0%

Value $3.007M Shares 1,170,370 Est. Cost $2.95 Unrealized -15.0%

— SOLTA MED INC 1.8%

Value $2.753M Shares 1,330,219 Est. Cost $2.28 Unrealized —

— CURIS INC 0.7%

Value $1.043M Shares 233,797 Est. Cost $3.19 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value $34,000 Shares 12,319 Est. Cost $2.52 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value $17,000 Shares 23,928 Est. Cost $0.59 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	3,150,000	$60.04M	39.6%	$21.56	—	COM	003654100
—	ENDOLOGIX INC	1,165,428	$34.03M	22.5%	$13.28	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	10,294,886	$18.84M	12.4%	$1.82	—	COM NEW	00509L703
—	HORIZON PHARMA INC	5,815,940	$18.01M	11.9%	$2.26	—	COM	44047T109
—	ZIOPHARM ONCOLOGY INC	2,764,908	$9.721M	6.4%	$1.96	—	COM	98973P101
—	CHINA CORD BLOOD CORP	1,037,690	$3.943M	2.6%	$2.81	—	SHS	G21107100
MNOV	MEDICINOVA INC	1,170,370	$3.007M	2.0%	$2.95	-15.0%	COM NEW	58468P206
—	SOLTA MED INC	1,330,219	$2.753M	1.8%	$2.28	—	COM	83438K103
—	CURIS INC	233,797	$1.043M	0.7%	$3.19	—	COM	231269101
—	ECHO THERAPEUTICS INC	12,319	$34,000	0.0%	$2.52	—	COM NEW	27876L206
—	PALATIN TECHNOLOGIES INC	23,928	$17,000	0.0%	$0.59	—	COM PAR $ .01	696077403